Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
G. von Minckwitz,C. -S. Huang,M. S. Mano,S. Loibl,E. P. Mamounas,M. Untch,N. Wolmark,P. Rastogi,A. Schneeweiss,A. Redondo,H. H. Fischer,W. Jacot,A. K. Conlin,C. Arce-Salinas,I. L. Wapnir,C. Jackisch,M. P. DiGiovanna,P. A. Fasching,J. P. Crown,P. Wuelfing,Z. Shao,E. Rota Caremoli,H. Wu,L. H. Lam,D. Tesarowski,M. Smitt,H. Douthwaite,S. M. Singel,C. E. Geyer New England Journal of Medicine（2019）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper